Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan M Brotchie

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
Scientific Reports|February 25, 2022
Enhanced firing of locus coeruleus neurons and SK channel dysfunction are conserved in distinct models of prodromal Parkinson's diseaseLina A Matschke, Marlene A Komadowski, Annette Stöhr, et al.
Brain, Behavior, and Immunity|October 31, 2024
Deep brain stimulation halts Parkinson's disease-related immune dysregulation in the brain and peripheral bloodRhonda L McFleder, Thomas Musacchio, Johanna Keller, et al.
Neurobiology of Disease|July 5, 2017
Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant α-synuclein rat model of parkinsonismJacqueline A Gleave, Lindsay R Arathoon, Dennison Trinh, et al.
Neurobiology of Disease|March 25, 2018
Corrigendum to "Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant α-synuclein rat model of parkinsonism" [Neurobiol. Dis. 106 (2018) 133-146]Jacqueline A Gleave, Lindsay R Arathoon, Dennison Trinh, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 21, 2012
A novel MDMA analogue, UWA-101, that lacks psychoactivity and cytotoxicity, enhances L-DOPA benefit in parkinsonian primatesTom H Johnston, Zak Millar, Philippe Huot, et al.
Nature Communications|November 20, 2023
Brain-to-gut trafficking of alpha-synuclein by CD11c<sup>+</sup> cells in a mouse model of Parkinson's diseaseRhonda L McFleder, Anastasiia Makhotkina, Janos Groh, et al.
Brain, Behavior, and Immunity|January 15, 2022
Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson's disease miceAkua A Karikari, Rhonda L McFleder, Eliana Ribechini, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Scientific Reports|February 25, 2022
Enhanced firing of locus coeruleus neurons and SK channel dysfunction are conserved in distinct models of prodromal Parkinson's diseaseLina A Matschke, Marlene A Komadowski, Annette Stöhr, et al.
Brain, Behavior, and Immunity|October 31, 2024
Deep brain stimulation halts Parkinson's disease-related immune dysregulation in the brain and peripheral bloodRhonda L McFleder, Thomas Musacchio, Johanna Keller, et al.
Neurobiology of Disease|July 5, 2017
Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant α-synuclein rat model of parkinsonismJacqueline A Gleave, Lindsay R Arathoon, Dennison Trinh, et al.
Neurobiology of Disease|March 25, 2018
Corrigendum to "Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant α-synuclein rat model of parkinsonism" [Neurobiol. Dis. 106 (2018) 133-146]Jacqueline A Gleave, Lindsay R Arathoon, Dennison Trinh, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 21, 2012
A novel MDMA analogue, UWA-101, that lacks psychoactivity and cytotoxicity, enhances L-DOPA benefit in parkinsonian primatesTom H Johnston, Zak Millar, Philippe Huot, et al.
Nature Communications|November 20, 2023
Brain-to-gut trafficking of alpha-synuclein by CD11c<sup>+</sup> cells in a mouse model of Parkinson's diseaseRhonda L McFleder, Anastasiia Makhotkina, Janos Groh, et al.
Brain, Behavior, and Immunity|January 15, 2022
Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson's disease miceAkua A Karikari, Rhonda L McFleder, Eliana Ribechini, et al.
Pageof 13